Skip to main content

GE Healthcare’s AngioViz Vascular Vision Software Receives FDA Clearance

June 9, 2011

Categories:
Interventional Radiology
Vascular

Application creates a new vision of vascular flow using a common imaging technique

WAUKESHA, WI – June 9, 2011 – GE Healthcare today announced the FDA clearance of AngioViz, an application that gives doctors a new visualization of vascular flow on a single image to help them make important decisions during complex interventional radiology procedures. AngioViz yields its information from Digital Subtraction Angiography (DSA), a technique commonly used to show the vascular anatomy.

“We are proud to offer our customers new information they will find valuable when planning and assessing complex interventional procedures. AngioViz takes the DSA technique to a new level,” said Chantal Le Chat, General Manager of Interventional Radiology, GE Healthcare.

Vascular imaging was revolutionized in the 1980s with the development of a technique called Digital Subtraction Angiography. The technique involves injecting a contrast dye into the vascular network while taking a rapid series of X-ray images. The first image, taken before the dye arrives in the field of view, is made into a mask image that is digitally removed, or “subtracted,” from the images showing contrast. The resulting images, which show only the contrast in the vessels, are used to display a two dimensional view of the vessels. Because the contrast is traveling through the vessels with the flow of blood, the arteries, capillary circulation, and then the veins are imaged in a DSA series. When used with today’s modern digital flat panel X-ray detectors, DSA produces excellent images of vascular anatomy over time.

But the anatomy of the vessels is only part of the story. Doctors want more information about the patterns and amount of blood flow to make better decisions during image guided interventions. They also want sequential information on a single image, instead of having to scan through a series of DSA images over and over. Finally they want to see how the flow of blood to an area of tissue has changed as a result of treatment.

A New Visualization of Vascular Flow
AngioViz provides a new visualization of the vascular flow seen in DSA imaging utilizing a technique called parametric imaging. AngioViz looks at each pixel in the image series and determines two things—the peak value of opacification caused by the contrast, and the time it takes for that pixel to reach peak opacification. These two parameters can be displayed as separate images or combined into a single color-coded image that represents parameters of vascular flow. This enables doctors to perceive parameters of flow quickly to support decision-making. In addition, AngioViz allows easy comparison of parametric images from different DSA acquisitions, such as pre- and post-treatment images. This can help physicians understand the impact on flow dynamics of various interventional treatments.

AngioViz bold flow visualization has the potential to be applied to a variety of clinical situations
· Help see where a blocked artery diminishes blood flow in the brain or other tissue
· Identify the timing and amount of blood flow in abnormal vessel anatomy
· Observe flow in abnormal tissue before and after treatment to support interventional oncology treatment
· Visualize peripheral artery blood flow before and after balloon angioplasty and stenting

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

For our latest news, please visit http://newsroom.gehealthcare.com

Contact Information

Holly Langdon
Name
Holly Langdon
Job Title
PR Manager
Division
GE Healthcare
Phone
1-414-721-3353
Fax
Mobile
1-414-429-6998
Email
holly.langdon@ge.com